The present invention relates to novel pharmaceutical compositions of alpha-dihydroergocryptine, capable of allowing transdermal and/or transmucosal absorption of the active ingredient, and to the use thereof as formulations in transdermal preparations, patches, gels, creams, ointments, solutions, buccal preparations or vaginal preparations, for the treatment of diseases of the nervous system or endocrine diseases.
PHARMACEUTICAL COMPOSITIONS OF ALPHA-DIHYDROERGOCRYPTINE FOR TRANSDERMAL AND/OR TRANSMUCOSAL USE
MONTI, DANIELA;BURGALASSI, SUSI;CHETONI, PATRIZIA;
2006-01-01
Abstract
The present invention relates to novel pharmaceutical compositions of alpha-dihydroergocryptine, capable of allowing transdermal and/or transmucosal absorption of the active ingredient, and to the use thereof as formulations in transdermal preparations, patches, gels, creams, ointments, solutions, buccal preparations or vaginal preparations, for the treatment of diseases of the nervous system or endocrine diseases.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
